Sa1808 ANTI-INTEGRIN AVB6 ANTIBODY IS A USEFUL PREDICTIVE BIOMARKER FOR RELAPSE OF ULCERATIVE COLITIS IN PATIENTS WITH MAYO ENDOSCOPIC SUBSCORE 0
Leggi →
Maggio 2024
Risultati per: Scoperta una nuova molecola anti-cancro
Questo è quello che abbiamo trovato per te
Sa1857 THE KEY ANTI-INFLAMMATORY BACTERIUM FAECALIBACTERIUM PRAUSNITZII IS MORE COMPLEX AND DIVERSE THAN PREVIOUSLY RECOGNISED: ANATOMIC, GEOGRAPHIC, AND GENOMIC DIFFERENCES IN THE EAST AND WEST AND IN HEALTH AND CROHN'S DISEASE. THE ENIGMA STUDY.
Leggi →
Maggio 2024
962 CALY-002, AN ANTI-IL-15 ANTIBODY, RESULTS IN HISTOLOGICAL AND CLINICAL IMPROVEMENT IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS IN A PHASE 1A/B STUDY
Leggi →
Maggio 2024
958 ATTAINING EARLY ANTI-TNF EXPOSURE TARGETS IS ASSOCIATED WITH IMPROVED RATES OF ENDOSCOPIC HEALING AND TRANSMURAL HEALING IN CHILDREN WITH CROHN'S DISEASE
Leggi →
Maggio 2024
870 ANTI-MICROBIOTA SYSTEMIC IGG DEPLETES PROTECTIVE BUTYRATEPRODUCING COMMENSALS IN IBD AND LONG PRECEDES CROHN'S DISEASE ONSET
Leggi →
Maggio 2024
Sa1232 RADIOIMMUNOTHERAPY OF AT-211-LABELED ANTI-FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4) ANTIBODY IS A PROMISING THERAPY FOR PERITONEAL DISSEMINATION OF GASTRIC CANCER: IN IMMUNOCOMPETENT MICE STUDY
Leggi →
Maggio 2024
399 MOLECULAR CHARACTERIZATION OF RESPONSE TO ETROLIZUMAB AND ANTI-TNF REVEALS TREATMENT REFRACTORY ULCERATIVE COLITIS IS ASSOCIATED WITH ABUNDANCE OF RESIDUAL NEUTROPHIL SUBSETS AND ACTIVE FIBROBLAST POPULATIONS
Leggi →
Maggio 2024
748 EXTENSIVE PROTEOMIC ANALYSIS IDENTIFIES A CROHN'S DISEASE CORE PROTEOME AND ANTI-TNF TREATMENT RESPONSE PROFILE FOR CHILDREN WITH CROHN'S DISEASE
Leggi →
Maggio 2024
583 CHARACTERIZING EPITOPES AND ISOTYPES OF CROHN'S DISEASEASSOCIATED ANTI-GRANULOCYTE MACROPHAGE-COLONY STIMULATING FACTOR ANTIBODIES.
Leggi →
Maggio 2024
627 TRANSCUTANEOUS AURICULAR VAGUS NERVE STIMULATION IMPROVES GASTRIC EMPTYING AND VISCERAL HYPERSENTITIVITY IN A RODENT MODEL OF FUNCTIONAL DYSPEPSIA VIA CHOLINERGIC ANTI-INFLAMMATORY PATHWAY
Leggi →
Maggio 2024
576 MICROBIOTA-INDUCED S100A11-RAGE AXIS UNDERLIES IMMUNOEVASION IN RIGHT-SIDED COLON ADENOMAS AND IS A THERAPEUTIC TARGET TO BOOST ANTI-PD1 EFFICACY
Leggi →
Maggio 2024
Su1114 A SHIFT IN PRESCRIBING PATTERNS OF ANTI-OBESITY MEDICATIONS – AN ASSESSMENT OF EVIDENCE-BASED PRACTICE IMPLEMENTATION
Leggi →
Maggio 2024
Su1042 IMPROVING RATES OF PRE-PROCEDURAL DIAGNOSTIC WORKUP BEFORE ANTI-REFLUX PROCEDURES
Leggi →
Maggio 2024
771 CELL CYCLE REGULATION VIA P21 PATHWAY MEDIATES CD4+ T CELL EXHAUSTION DURING ANTI-TUMOR RESPONSE IN COLORECTAL CANCER
Leggi →
Maggio 2024
Sa1367 BOTH 14-DAY VONOPRAZAN TRIPLE THERAPY AND 14-DAY RABEPRAZOLE REVERSE HYBRID THERAPY ARE SUPERIOR TO 14-DAY VONOPRAZAN HIGH-DOSE DUAL THERAPY FOR THE FIRST-LINE ANTI-H. PYLORI TREATMENT IN POPULATION WITH HIGH RATES OF ANTIBIOTIC RESISTANCE
Leggi →
Maggio 2024
709 FUSOBACTERIUM NUCLEATUM FACILITATES ANTI-PD-1 THERAPY IN MICROSATELLITE STABLE COLORECTAL CANCER
Leggi →
Maggio 2024
